Impax Asset Management Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,088
Closed -$1.01M 389
2023
Q3
$1.01M Sell
4,088
-78
-2% -$21.3K ﹤0.01% 275
2023
Q2
$1.26M Sell
4,166
-433
-9% -$120K 0.01% 262
2023
Q1
$1.21M Sell
4,599
-261
-5% -$66.3K 0.01% 265
2022
Q4
$1.17M Sell
4,860
-570
-10% -$128K 0.01% 255
2022
Q3
$998K Buy
5,430
+1,561
+40% +$311K 0.01% 266
2022
Q2
$650K Buy
3,869
+1,117
+41% +$240K ﹤0.01% 305
2022
Q1
$690K Hold
2,752
﹤0.01% 319
2021
Q4
$707K Sell
2,752
-220
-7% -$53.8K ﹤0.01% 319
2021
Q3
$721K Sell
2,972
-19,978
-87% -$4.88M ﹤0.01% 311
2021
Q2
$4.75M Hold
22,950
0.02% 198
2021
Q1
$4.32M Buy
+22,950
New +$4.05M 0.02% 201

Other funds holding HCA

Impax Asset Management Group's HCA Position: Q4 2023 in Review

Impax Asset Management Group sold out of HCA Healthcare (HCA) in Q4 2023, closing a stake of 4,088 shares — an estimated $1.01M sold.

Impax Asset Management Group first reported a position in HCA in Q1 2021 and held it in 11 quarters. The position peaked at $4.75M in Q2 2021. 1,056 funds tracked by Wall St. Rank hold HCA as of Q4 2023.

  • Impax Asset Management Group reported no remaining HCA Healthcare position as of Q4 2023 after selling out during the quarter.
  • Impax Asset Management Group sold 4,088 HCA Healthcare shares in Q4 2023, an estimated $1.01M.
  • Impax Asset Management Group first reported a position in HCA Healthcare in Q1 2021 and held it in 11 quarters.
  • Impax Asset Management Group's HCA Healthcare position peaked at $4.75M in Q2 2021.
  • 1,056 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2023.

Based on Impax Asset Management Group's 13F filing for Q4 2023, filed 26 Jan 2024.